Loading...

Scilex Holding Company

SCLX•NASDAQ
Healthcare
Drug Manufacturers - General
$6.69
$-0.25(-3.60%)
U.S. Market opens in 15h 23m

Scilex Holding Company (SCLX) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap56.8M
P/E Ratio-0.18
EPS (TTM)$-36.48
ROE1.90%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.10
3 Months$11.45
1 Year Target$22.10

SCLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scilex Holding Company (SCLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.18 and a market capitalization of 56.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.60%
5-Day Change
1.52%
1-Month Change
1.21%
3-Month Change
-39.13%
6-Month Change
-58.98%
Year-to-Date (YTD) Change
-45.16%
1-Year Change
51.02%
3-Year Change
-97.37%
5-Year Change
-98.08%
All-Time (Max) Change
-98.06%

Contact Information

https://www.scilexholding.com
650-516-4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

115 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions